EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic implications and diagnostic significance of TFE3 rearrangement in renal cell carcinoma

Carmina Muñoz Bastidas, Mario Tapia Tapia, Andrés Calva López, Vanessa Talavera Cobo, Juan Colombas Vives, Eduardo Miraval Wong, Cristina Gutiérrez Castané, Francisco Javier Ancizu Marckert, Marcos Torres Roca, Luis Labairu Huerta, Fernando Diez-Caballero Alonso, José Enrique Robles García und 4 weitere

World Journal of Urology · 2024

DOI: 10.1007/s00345-024-05290-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Urology, 2024. Verfasst von Carmina Muñoz Bastidas und 15 weiteren Autor:innen. Beteiligte Einrichtung: University of Navarra Clinic, Urology, Pamplona, Spain. cmunozbasti@unav.es. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Kidney Neoplasms, Gene Rearrangement. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de Navarra.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To investigate the impact of TFE3 rearrangement, analyzing clinicopathological features that influence renal cell carcinoma (RCC) recurrence, and clarify the role of immunohistochemistry (IHC) staining in diagnosis.

Methods

We screened patients diagnosed of clear cell RCC (ccRCC), fluorescence in situ hybridization (FISH) was performed on all TFE3 positive IHC tumors. Clinicopathological and survival features were collected for analysis.

Results

Out of 695 patients treated for renal tumors, 478 (68.7%) were ccRCC and 22 were suspected of TFE3 rearrangement based on IHC. Subsequent testing revealed 8 (1.15%) were positive in the FISH test (TFE3-rearranged-RCC) and 14 (2.01%) tested negative. No significant differences were noted in general characteristics among the three groups, except for age, TFE3-rearranged-RCC were younger than ccRCC (median age, 49 vs. 58 years, p = 0.02). TFE3-rearranged-RCC exhibited a significant higher recurrence rate compared to ccRCC (50% vs 18.8%) and multivariate analysis revealed that TFE3 rearrangement, along with tumor size and metastasis, was an independent prognostic factor for recurrence (HR = 4.6; 95% CI 1.1-21.2; p = 0.05). Survival analysis demonstrated a significant shorter PFS (progression-free survival) for TFE3-rearranged-RCC compared to ccRCC.

Conclusions

TFE3 rearrangement is an independent prognostic factor for recurrence and contributes to a worse PFS, suggesting the necessity of careful follow-up. Diagnosis should be confirmed using FISH due to low specificity of IHC. Further studies are needed to confirm TFE3 IHC staining as a prognostic factor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsKidney NeoplasmsGene RearrangementHumansMiddle AgedMaleFemalePrognosisAdultAgedRetrospective StudiesNeoplasm Recurrence, LocalSurvival RateImmunohistochemistryIn Situ Hybridization, Fluorescence

Stichwörter der Autor:innen

Fluorescence in situ hybridizationPrognosisRenal cell carcinomaTFE3TFE3-rearranged-RCC

Substanzen

TFE3 protein, humanBasic Helix-Loop-Helix Leucine Zipper Transcription Factors

Autor:innen und Institutionen

  • University of Navarra Clinic, Urology, Pamplona, Spain. cmunozbasti@unav.es.
  • University of Navarra Clinic, Urology, Pamplona, Spain.
  • University of Navarra Clinic, Pathology, Pamplona, Spain.
  • University of Navarra Clinic, Urology, Madrid, Spain.

Förderung

  • Universidad de Navarra

Zitieren

APA

Muñoz Bastidas, C., Tapia, M. T., López, A. C., Cobo, V. T., Vives, J. C., Wong, E. M., Castané, C. G., Marckert, F. J. A., Roca, M. T., Huerta, L. L., Alonso, F. D., García, J. E. R., Aubá, F. V., Padilla, D. G., López, B. M., & Zalabardo, D. S. (2024). Prognostic implications and diagnostic significance of TFE3 rearrangement in renal cell carcinoma. World Journal of Urology. https://doi.org/10.1007/s00345-024-05290-w

Vancouver

Muñoz Bastidas C, Tapia MT, López AC, Cobo VT, Vives JC, Wong EM, et al. Prognostic implications and diagnostic significance of TFE3 rearrangement in renal cell carcinoma. World Journal of Urology. 2024. doi:10.1007/s00345-024-05290-w

BibTeX
@article{MuozBastidas2024,
  author = {Muñoz Bastidas, Carmina and Tapia, Mario Tapia and López, Andrés Calva and Cobo, Vanessa Talavera and Vives, Juan Colombas and Wong, Eduardo Miraval and Castané, Cristina Gutiérrez and Marckert, Francisco Javier Ancizu and Roca, Marcos Torres and Huerta, Luis Labairu and Alonso, Fernando Diez-Caballero and García, José Enrique Robles and Aubá, Felipe Villacampa and Padilla, Daniel González and López, Bernardino Miñana and Zalabardo, Daniel Sánchez},
  title = {Prognostic implications and diagnostic significance of TFE3 rearrangement in renal cell carcinoma},
  journal = {World Journal of Urology},
  year = {2024},
  doi = {10.1007/s00345-024-05290-w}
}
Kostenlos starten →